Background. Several studies demonstrated that mesenchymal stem cells (MSCs) reverse
acute kidney injury (AKI) by a paracrine mechanism rather than by MSC transdifferentiation …

Administration of mesenchymal stem cells (MSCs) improves the recovery from acute kidney
injury (AKI). The mechanism may involve paracrine factors promoting proliferation of …

Aims: Several studies have demonstrated administration of mesenchymal stem cells (MSC)
could reverse kidney injury by paracrine mechanisms rather than by MSC …

Several studies demonstrated that treatment with mesenchymal stem cells (MSCs) reduces
cisplatin mortality in mice. Microvesicles (MVs) released from MSCs were previously shown …

Several studies have demonstrated that mesenchymal stem cells have the capacity to
reverse acute and chronic kidney injury in different experimental models by paracrine …

Endothelial progenitor cells are known to reverse acute kidney injury by paracrine
mechanisms. We previously found that microvesicles released from these progenitor cells …

Introduction Studies have shown that stem cells exert their therapeutic effects on acute
kidney injury (AKI) through paracrine/endocrine actions. If the protective effect is mediated in …

Acute kidney injury (AKI) is a major clinical problem in which a critical vascular,
pathophysiological component is recognized. We demonstrated previously that …

We recently demonstrated the use of in vitro expanded kidney-derived mesenchymal stem
cells (KMSC) protected peritubular capillary endothelial cells in acute renal ischemia …

BACKGROUND: Ischemia and reperfusion injury (I/R) is the major cause of acute renal
failure (ARF) with high mortality rates. Because alternative therapies are needed, we …